The NanoOnco Team
Our team includes experts and medical professionals from oncology, surgery, materials science and engineering backgrounds.
Our Team

Dr. Raymond Decker – PhD
- Founder and Chief Technical Officer
- Adjunct Professor of Materials Science & Engineering
University of Michigan - Member, National Academy of Engineering
- Contact Dr. Decker

Dr. Stephen LeBeau – PhD
- President
- Materials Science & Engineering
- Serial Entrepreneur
- Contact Dr. LeBeau

Anthony Melkent
- VP of Technology and Quality Control
- Device Designer
- BS in Mechanical Engineering, MBA

Ed Snape, PhD
- Business Strategy Advisor
- Principal & Co-Founder, Nexus Medical
- 8 Biomedical Startups
- University of Leeds (UK)

Deepak Nagrath, Ph.D.
- Scientific Advisory Board Member
- Professor, Biomedical Engineering
University of Michigan - Metal-Based Cancer Immunotherapy

Dr. Kiran Lagisetty – MD
- University of Michigan Asst Professor, Lung Oncologist & Practicing Surgeon
- University of Michigan Medical School/Hospital
- Ann Arbor VA Hospital

Dr. Claudia Loebel – MD
- Scientific Advisory Board Member
- PhD & MD, Adjunct Professor, Materials Science and Engineering
University of Michigan - Assistant Professor, Bioengineering
University of Pennsylvania

Heng Wang
- PhD Candidate, U-M Biomedical Engineering
MS John Hopkins University - Brain Cancer Research, Dana-Farber Cancer Institute
Our Solution
A unique BioMg 250 implant is in development with the University of Michigan/US Veterans Administration/NanoOnco team to deliver anti-cancer treatment into the tumor, reducing harmful effects on the body. The novel BioMg 250 wire is one part of a 3 part system that also includes a novel insertion device and an ultrasound device to monitor placement of wires in a tumor.
| Number of BioMg 250 Wires | Lung Cancer Cell Count (105) |
|---|---|
| 0 | 2.35 |
| 1 | 1.65 |
| 3 | 0.45 |
Increased BioMg 250 Boosts Lung Cancer Cell Killing (4 Days In Vitro)
D. Nagrath & S. Ejike – Sponsored by Michigan Materials Research Institute & NanoOnco, Inc
| Combination | Lung Cancer Cell Count (105) (p=0.001%) |
|---|---|
| 1 Bare BioMg 250 Wire | 1.65 |
| 1 BioMg 250 Wire with 10 µg* Cisplatin Coating | 0.70 |
| 1 BioMg 250 Wire with 20 µg* Cisplatin Coating | 0.60 |
* Cisplatin loading is 0.001% of Normal Chemotherapy IV Whole Body Treatments
D. Nagrath & S. Ejike – Sponsored by Michigan Materials Research Institute & NanoOnco

